HR 4882 United States House · 118th Congress

Clinical Laboratory Price Transparency Act of 2023

The Clinical Laboratory Price Transparency Act of 2023 requires Medicare-participating laboratories to publicly disclose prices for specific clinical tests, including discounted cash prices and negotiated rates with health insurance plans. Starting January 1, 2025, labs must post this information on a standardized website (with annual updates) in a format established by the Department of Health and Human Services by 2028. Non-compliant labs face civil penalties of up to $300 per day after a 90-day correction period. This applies only to laboratories providing tests listed as "shoppable services" under Medicare (e.g., common blood or urine tests, excluding advanced diagnostic tests).
Bill status in committee 1 of 4 stages cleared
Introduction
Jul 2023
Committee Review
Floor Vote
President
Introduced Jul 25, 2023 Last action Dec 17, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
3
Dec 17, 2024
Committee
Referred to the Subcommittee on Health.
lower
Jul 28, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jul 25, 2023
Committee
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jul 25, 2023
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Carol D. Miller
Carol D. Miller
RRepublican
WV
1